Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GDRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGDRXGoodRx$4.64+0.2%$4.55$3.82▼$9.26$1.78B1.251.38 million shs795,535 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGDRXGoodRx+0.22%-3.33%+4.74%-2.73%-33.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGDRXGoodRx3.2483 of 5 stars3.44.00.00.02.11.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGDRXGoodRx 2.73Moderate Buy$7.8468.99% UpsideCurrent Analyst Ratings BreakdownLatest GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/10/2025GDRXGoodRxTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.50 ➝ $5.502/28/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$9.00 ➝ $8.00(Data available from 5/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGDRXGoodRx$792.32M2.25$0.39 per share11.77$1.93 per share2.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGDRXGoodRx-$8.87M$0.05N/A25.782.46-2.05%5.35%2.51%5/7/2025 (Estimated)Latest GDRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025GDRXGoodRx$0.09N/AN/AN/A$202.25 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGDRXGoodRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGDRXGoodRx0.705.485.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGDRXGoodRx63.77%Insider OwnershipCompanyInsider OwnershipGDRXGoodRx4.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGDRXGoodRx950383.61 million365.25 millionOptionableGDRX HeadlinesRecent News About These CompaniesRaymond James Financial Inc. Purchases New Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)May 2 at 3:42 AM | marketbeat.comWells Fargo & Company Cuts GoodRx (NASDAQ:GDRX) Price Target to $7.00May 1 at 11:24 AM | marketbeat.comGoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?May 1 at 3:50 AM | finance.yahoo.comGoodRx Holdings, Inc. (GDRX) Reports Next Week: Wall Street Expects Earnings GrowthApril 30 at 11:06 AM | zacks.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $7.93 Consensus Price Target from AnalystsApril 29 at 2:11 AM | americanbankingnews.comCanada Pension Plan Investment Board Invests $292,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)April 28, 2025 | marketbeat.comGeode Capital Management LLC Has $4.99 Million Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)April 28, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Rating of "Moderate Buy" from AnalystsApril 28, 2025 | marketbeat.com67,474 Shares in GoodRx Holdings, Inc. (NASDAQ:GDRX) Bought by Russell Investments Group Ltd.April 27, 2025 | marketbeat.com3 Reasons to Sell GDRX and 1 Stock to Buy InsteadApril 23, 2025 | finance.yahoo.comTD Cowen Sticks to Their Buy Rating for GoodRx Holdings (GDRX)April 22, 2025 | markets.businessinsider.comOverview of the American Telehealth IndustryApril 21, 2025 | uk.finance.yahoo.comWhy GoodRx Holdings (GDRX) Is Among the Best Telehealth Stocks to Buy NowApril 21, 2025 | insidermonkey.comRenaissance Technologies LLC Sells 106,000 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)April 17, 2025 | marketbeat.comExodusPoint Capital Management LP Invests $322,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)April 15, 2025 | marketbeat.comVanguard Group Inc. Has $38.94 Million Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX)April 15, 2025 | marketbeat.comEVR Research LP Invests $1.76 Million in GoodRx Holdings, Inc. (NASDAQ:GDRX)April 14, 2025 | marketbeat.comTruist Financial Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock PriceApril 12, 2025 | marketbeat.comGoodRx price target lowered to $5.50 from $6.50 at TruistApril 11, 2025 | markets.businessinsider.comGoodRx Announces Date for First Quarter 2025 Earnings Release and Conference CallApril 9, 2025 | businesswire.comGoodRx Announces Date for First Quarter 2025 Earnings Release and Conference CallApril 9, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGDRX Company DescriptionsGoodRx NASDAQ:GDRX$4.64 +0.01 (+0.22%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$4.62 -0.02 (-0.43%) As of 05/1/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Crushes Earnings, What’s Next for MSFT Stock? McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away Broadcom: Buy, Hold, Sell? AI & Acquistions Paint Strong Picture Hershey Hits the Sweet Spot for Defensive Investors A Bull Case for Adobe Stock Remains Today AMD Stock Signals Strong Buy Ahead of Earnings BigBear.ai: A Short-Squeeze Is Possible, a Sharp Drop Is Likely Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
